| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 132.1 | 134.5 |
| Profit before tax | 9.3 | 18.3 |
| Net income | 5.4 | 14.2 |
| EPS (diluted, $ a share) | $0.12 | $0.30 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Net income, year on year | -61.8% |
|---|---|
| Revenue, year on year | -1.8% |
| Operating margin | 9.1% |
10-Q filed with the SEC, NYSE: CLB. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Core Laboratories Inc.: key numbers
- Share price
- $8.45Close, Nov 16
- Market cap
- $387M
- Shares outstanding
- 45.82MLatest SEC cover page
- Sector
- Energy & Transportation
- Industry
- Oil & Gas Field Services, NECSIC 1389
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Core Laboratories Inc.
All →Core Laboratories Financial Results
Core Laboratories reported Q3 2026 revenue of $132.1 million, up 6% sequentially, driven by international demand for laboratory services and strong U.S. product sales. The company achieved GAAP EPS of $0.12 and announced a quarterly cash dividend of $0.01 per share. Management noted improving demand across international regions, particularly in the Middle East and Asia-Pacific, despite ongoing geopolitical headwinds.
- Term
- Q3 2026
“Our third quarter results delivered sequential revenue growth across both of our operating segments. International revenue was up in Europe-Africa, Asia-Pacific, Latin America, and the Middle East. There was a gradual improvement in activity in the Middle East, particularly late in the quarter.”
Larry Bruno, CEO
“Looking at the mid to long term, we see our key international regions positioned for growth, including long-cycle offshore exploration and appraisal projects. Face-to-face meetings with clients throughout Asia-Pacific during the third quarter reinforced our view that the region is entering a period of sustained activity growth, with projects advancing across both conventional and unconventional plays.”
Larry Bruno, CEO